Alaa M Ali

7PUBLICATIONS
14CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 15, 2026
Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders.

|Oct 10, 2025
Pretransplant MRD and chemotherapy in AML: A transplant physician's perspective.

Alaa Ali

|Feb 26, 2025
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies.

Scott D Rowley, Maher Albitar, Melissa F Baker

|Oct 19, 2022
Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.

Michael R Cook, C Scott Dorris, Kepher H Makambi

|May 13, 2022
CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights.

Alaa Ali, Andre Goy, Kieron Dunleavy

|Oct 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.

Alaa M Ali, Daniel Weisel, Feng Gao

Pageof 2

Frequent Collaborators

2 joint publications

Scott Rowley

1 joint publications

Michael R Cook

1 joint publications

C Scott Dorris

1 joint publications

Ayman Saad